NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Biomia

Biomia

Private
CopenhagenHealthcare & Life Scienceshttps://www.biomia.com/

Last Round

Accelerator

Feb 9, 2026

Total Funding Raised

$15.2M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Biomia is a synthetic biology company that engineers and develops nature-inspired small molecule therapeutics to treat central nervous system (CNS) disorders such as pain, addiction, and depression.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical AI, Mental Health

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Application

Keywords

synthetic biologyAI drug discoverydrug discovery platformsynbioyeast-based biomanufacturingsmall molecule therapeuticsprecision fermentationbiomanufacturingMonoterpene Indole AlkaloidsMIAsgenetically engineered yeastCNS disordersmental health therapeuticsaddiction treatmentpain management

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Biomia Comparables

Compare Biomia with similar companies based on industry and business-model similarity.

Biomia comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

Biomia Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorFeb 9, 2026
Pre SeedSep 26, 2023
GrantJan 1, 2019
View all Funding Rounds

Key People

Founding team and executive leadership

Jie Zhang

Co-Founder & CTO Of Biomia Aps

Founding Team

Michael Krogh Jensen

Chief Executive Officer

Executive Team

Otto Rasmussen

CFO

Executive Team

Biomia Investors

Notable investors and investment history

Biomia investors
InvestorRounds
Nucleus CapitalPre Seed
Novo Nordisk FoundationPre Seed
Amino CollectivePre Seed
One MindAccelerator
European UnionGrant, Pre Seed
BioInnovation InstitutePre Seed, Grant
View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 9, 2026

    Secured funding from One Mind.

  • Jul 3, 2025

    Monthly visitors increased 124% MoM.

View all signals

Biomia Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Biomia Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Biomia's valuation, stock price, and market status.

Firmographic Details

HeadquartersCopenhagen
Employee Range9
Year Founded2022
Last FundingFeb 9, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.